Ardelyx | ARDX - Operating Profit


Ardelyx reported $4.67M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Amgen USD 3.96B 464M Dec/2025
Ardelyx USD 4.67M 19.07M Sep/2025
aTyr Pharma USD -26.74M 6.43M Sep/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Curis USD -12.51M 40K Jun/2024
Sanofi EUR 1.5B 2.29B Dec/2025
TG Therapeutics USD 29.36M 5.48M Sep/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xoma USD -15.64M 5.56M Sep/2024